{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:07:39Z","timestamp":1789978059889,"version":"4.0.1"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institute on Drug Abuse Intramural Research Program"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.brainres.2018.09.023","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:02:30Z","timestamp":1537401750000},"page":"91-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"special_numbering":"C","title":["Dynorphin\/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders"],"prefix":"10.1016","volume":"1713","author":[{"given":"Hugo A.","family":"Tejeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Bonci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2018.09.023_b0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/npp.2017.133","article-title":"kappa-Opioid receptor activation in dopamine neurons disrupts behavioral inhibition","volume":"43","author":"Abraham","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0010","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0653-18.2018","article-title":"Estrogen regulation of GRK2 inactivates kappa opioid receptor signaling mediating analgesia, but not aversion","author":"Abraham","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0015","first-page":"127","article-title":"Cloning and characterization of multiple opioid receptors","volume":"161","author":"Akil","year":"1996","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.brainres.2018.09.023_b0020","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neuron.2015.08.019","article-title":"Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward","volume":"87","author":"Al-Hasani","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0025","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/acer.13406","article-title":"Role of the dynorphin\/kappa opioid receptor system in the motivational effects of ethanol","volume":"41","author":"Anderson","year":"2017","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.brainres.2018.09.023_b0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/pr.115.010512","article-title":"Dopamine\u2019s actions in primate prefrontal cortex: challenges for treating cognitive disorders","volume":"67","author":"Arnsten","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainres.2018.09.023_b0035","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.celrep.2017.01.030","article-title":"Projection-target-defined effects of orexin and dynorphin on VTA dopamine neurons","volume":"18","author":"Baimel","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.brainres.2018.09.023_b0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-3565(25)10296-6","article-title":"Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats","volume":"264","author":"Bals-Kubik","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2018.09.023_b0045","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.neuron.2018.01.006","article-title":"Dopamine\u2019s effects on corticostriatal synapses during reward-based behaviors","volume":"97","author":"Bamford","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0050","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.neuron.2004.05.019","article-title":"Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons","volume":"42","author":"Beckstead","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0055","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41593-018-0152-y","article-title":"What does dopamine mean?","volume":"21","author":"Berke","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0060","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1046\/j.1471-4159.2000.0751763.x","article-title":"Defective prodynorphin processing in mice lacking prohormone convertase PC2","volume":"75","author":"Berman","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2018.09.023_b0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41593-017-0023-y","article-title":"Accumbal D2 cells orchestrate innate risk-avoidance according to orexin signals","volume":"21","author":"Blomeley","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0070","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuron.2006.01.016","article-title":"Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine","volume":"49","author":"Borgland","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0075","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1124\/jpet.102.037663","article-title":"Developmental changes in opioid peptides and their receptors in Cpe(fat)\/Cpe(fat) mice lacking peptide processing enzyme carboxypeptidase E","volume":"303","author":"Boudarine","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2018.09.023_b0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ijnp\/pyx079","article-title":"Reversal of stress-induced social interaction deficits by buprenorphine","volume":"21","author":"Browne","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-010-1806-y","article-title":"Kinase cascades and ligand-directed signaling at the kappa opioid receptor","volume":"210","author":"Bruchas","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008528","article-title":"CRF1-R activation of the dynorphin\/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior","volume":"4","author":"Bruchas","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2018.09.023_b0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.09.023_b0100","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.neuron.2011.06.011","article-title":"Selective p38alpha MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction","volume":"71","author":"Bruchas","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0105","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2012.05.005","article-title":"kappa-opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction","volume":"35","author":"Butelman","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.celrep.2012.05.011","article-title":"Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing","volume":"2","author":"Cachope","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.brainres.2018.09.023_b0115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2018.09.023_b0120","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/da.22500","article-title":"Kappa-opioid antagonists for psychiatric disorders: from bench to clinical trials","volume":"33","author":"Carlezon","year":"2016","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.brainres.2018.09.023_b0125","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/npp.2009.183","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats","volume":"35","author":"Carr","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00213-010-1832-9","article-title":"Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats","volume":"210","author":"Carr","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0135","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nrn3621","article-title":"DSM-5 and RDoC: progress in psychiatry research?","volume":"14","author":"Casey","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.6120570","article-title":"Dynorphin is a specific endogenous ligand of the kappa opioid receptor","volume":"215","author":"Chavkin","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.brainres.2018.09.023_b0145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0306-4522(00)00417-6","article-title":"Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine","volume":"101","author":"Chefer","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.09.023_b0150","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1523\/JNEUROSCI.0854-05.2005","article-title":"Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine","volume":"25","author":"Chefer","year":"2005","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0155","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1038\/npp.2013.171","article-title":"Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion","volume":"38","author":"Chefer","year":"2013","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0160","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1749-6632.1999.tb09327.x","article-title":"Modulation of cocaine-induced sensitization by kappa-opioid receptor agonists. Role of the nucleus accumbens and medial prefrontal cortex","volume":"877","author":"Chefer","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2018.09.023_b0165","doi-asserted-by":"crossref","first-page":"RC168","DOI":"10.1523\/JNEUROSCI.21-19-j0003.2001","article-title":"Orexin (hypocretin) neurons contain dynorphin","volume":"21","author":"Chou","year":"2001","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pnpbp.2015.01.001","article-title":"Kappa opioid receptor signaling in the brain: circuitry and implications for treatment","volume":"62","author":"Crowley","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.09.023_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: drivers to addiction?","author":"Darcq","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/mcne.1994.1039","article-title":"Distribution of kappa opioid receptor mRNA in adult mouse brain: an in situ hybridization histochemistry study","volume":"5","author":"DePaoli","year":"1994","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0185","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0022-3565(25)39324-9","article-title":"Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies","volume":"266","author":"Devine","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2018.09.023_b0190","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"PNAS"},{"key":"10.1016\/j.brainres.2018.09.023_b0195","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/FBP.0000000000000155","article-title":"Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin\/kappa-opioid receptor system","volume":"26","author":"Donahue","year":"2015","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-010-1836-5","article-title":"Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens","volume":"210","author":"Ebner","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0205","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nn.4482","article-title":"Circuit specificity in the inhibitory architecture of the VTA regulates cocaine-induced behavior","volume":"20","author":"Edwards","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0210","doi-asserted-by":"crossref","first-page":"12917","DOI":"10.1523\/JNEUROSCI.2444-15.2015","article-title":"Kappa opioid receptor-induced aversion requires p38 MAPK activation in VTA dopamine neurons","volume":"35","author":"Ehrich","year":"2015","journal-title":"J. Neurosc.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0215","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/npp.2014.330","article-title":"Evaluation of opioid modulation in major depressive disorder","volume":"40","author":"Ehrich","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neuropharm.2018.07.034","article-title":"Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis","volume":"140","author":"Erikson","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0225","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1126\/science.1335167","article-title":"Cloning of a delta opioid receptor by functional expression","volume":"258","author":"Evans","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.brainres.2018.09.023_b0230","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1523\/JNEUROSCI.0117-17.2017","article-title":"dopamine inhibition differentially controls excitability of substantia nigra dopamine neuron subpopulations through T-type calcium channels","volume":"37","author":"Evans","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0235","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0143-4179(85)90053-8","article-title":"Dynorphin-containing pathways in the substantia nigra and ventral tegmentum: a double labeling study using combined immunofluorescence and retrograde tracing","volume":"5","author":"Fallon","year":"1985","journal-title":"Neuropeptides"},{"key":"10.1016\/j.brainres.2018.09.023_b0240","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/appi.ajp.2015.15070921","article-title":"Opioid modulation with buprenorphine\/samidorphan as adjunctive treatment for inadequate response to antidepressants: a randomized double-blind placebo-controlled trial","volume":"173","author":"Fava","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2018.09.023_b0245","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1523\/JNEUROSCI.21-16-06370.2001","article-title":"Dopamine D1 and NMDA receptors mediate potentiation of basolateral amygdala-evoked firing of nucleus accumbens neurons","volume":"21","author":"Floresco","year":"2001","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0250","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00213-006-0404-5","article-title":"Mesocortical dopamine modulation of executive functions: beyond working memory","volume":"188","author":"Floresco","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0255","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1523\/JNEUROSCI.4331-05.2006","article-title":"Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location","volume":"26","author":"Ford","year":"2006","journal-title":"J Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0260","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1152\/jn.00963.2006","article-title":"Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents","volume":"97","author":"Ford","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.brainres.2018.09.023_b0265","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00213-007-1067-6","article-title":"Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum","volume":"197","author":"Gehrke","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0270","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1073\/pnas.76.12.6666","article-title":"Dynorphin-(1\u201313), an extraordinarily potent opioid peptide","volume":"76","author":"Goldstein","year":"1979","journal-title":"PNAS"},{"key":"10.1016\/j.brainres.2018.09.023_b0275","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1073\/pnas.78.11.7219","article-title":"Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide","volume":"78","author":"Goldstein","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2018.09.023_b0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0006-8993(82)90930-1","article-title":"Immunoreactive dynorphin in human brain and pituitary","volume":"233","author":"Gramsch","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.09.023_b0285","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.neuron.2012.12.034","article-title":"Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity","volume":"77","author":"Graziane","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0290","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1113\/JP274190","article-title":"Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through kappa-opioid receptors","volume":"595","author":"Hawes","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.brainres.2018.09.023_b0295","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1021\/acschemneuro.5b00277","article-title":"Enhanced dopamine release by dopamine transport inhibitors described by a restricted diffusion model and fast-scan cyclic voltammetry","volume":"7","author":"Hoffman","year":"2016","journal-title":"ACS Chem. Neurosci."},{"issue":"1436\u20131450","key":"10.1016\/j.brainres.2018.09.023_b0300","article-title":"Dynamic nigrostriatal dopamine biases action selection","volume":"93","author":"Howard","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0305","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature12475","article-title":"Prolonged dopamine signalling in striatum signals proximity and value of distant rewards","volume":"500","author":"Howe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2018.09.023_b0310","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1176\/appi.ajp.2014.14020138","article-title":"The NIMH research domain criteria (RDoC) project: precision medicine for psychiatry","volume":"171","author":"Insel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2018.09.023_b0315","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.1523\/JNEUROSCI.0381-09.2009","article-title":"Retrograde opioid signaling regulates glutamatergic transmission in the hypothalamus","volume":"29","author":"Iremonger","year":"2009","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0320","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00213-010-1803-1","article-title":"Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse","volume":"210","author":"Jackson","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0325","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00213-012-2716-y","article-title":"Effects of the kappa opioid receptor antagonist, norbinaltorphimine, on stress and drug-induced reinstatement of nicotine-conditioned place preference in mice","volume":"226","author":"Jackson","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0330","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0006-291X(79)90394-2","article-title":"alpha-Neo-endorphin: a \u201cbig\u201d Leu-enkephalin with potent opiate activity from porcine hypothalami","volume":"86","author":"Kangawa","year":"1979","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2018.09.023_b0335","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.irn.2017.08.001","article-title":"Dynorphin\/kappa opioid receptor signaling in preclinical models of alcohol, drug, and food addiction","volume":"136","author":"Karkhanis","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.brainres.2018.09.023_b0340","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/npp.2016.21","article-title":"Early-life social isolation stress increases kappa opioid receptor responsiveness and downregulates the dopamine system","volume":"41","author":"Karkhanis","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0345","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.4088\/JCP.13m08725","article-title":"Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults","volume":"75","author":"Karp","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainres.2018.09.023_b0350","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.79.21.6480","article-title":"Rimorphin, a unique, naturally occurring [Leu]enkephalin-containing peptide found in association with dynorphin and alpha-neo-endorphin","volume":"79","author":"Kilpatrick","year":"1982","journal-title":"PNAS"},{"key":"10.1016\/j.brainres.2018.09.023_b0355","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/npp.2015.183","article-title":"Dissociating motivational from physiological withdrawal in alcohol dependence: role of central amygdala kappa-opioid receptors","volume":"41","author":"Kissler","year":"2016","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0360","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuropharm.2014.07.016","article-title":"Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1\/2-dependent mechanism","volume":"86","author":"Kivell","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0365","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.107.127415","article-title":"Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats","volume":"323","author":"Knoll","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2018.09.023_b0370","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.biopsych.2011.03.017","article-title":"Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats","volume":"70","author":"Knoll","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.09.023_b0375","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0380","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1523\/JNEUROSCI.23-01-00007.2003","article-title":"Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins\/hypocretins","volume":"23","author":"Korotkova","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0385","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1111\/j.1460-9568.2006.04792.x","article-title":"Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat","volume":"23","author":"Korotkova","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0390","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature05506","article-title":"Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models","volume":"445","author":"Kreitzer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2018.09.023_b0395","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2013.03.019","article-title":"Reward and aversion in a heterogeneous midbrain dopamine system","author":"Lammel","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0400","doi-asserted-by":"crossref","first-page":"19168","DOI":"10.1073\/pnas.0910705106","article-title":"Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking","volume":"106","author":"Land","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.brainres.2018.09.023_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2017.10.006","article-title":"Model-based predictions for dopamine","volume":"49","author":"Langdon","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.brainres.2018.09.023_b0410","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Le Merrer","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.brainres.2018.09.023_b0415","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainres.2015.12.062","article-title":"Dual projections of single orexin- or CART-immunoreactive, lateral hypothalamic neurons to the paraventricular thalamic nucleus and nucleus accumbens shell in the rat: Light microscopic study","volume":"1634","author":"Lee","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.09.023_b0420","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1523\/JNEUROSCI.2053-12.2012","article-title":"Repeated stress dysregulates kappa-opioid receptor signaling in the dorsal raphe through a p38alpha MAPK-dependent mechanism","volume":"32","author":"Lemos","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0425","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.biopsych.2011.11.015","article-title":"Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling","volume":"71","author":"Li","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.09.023_b0430","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.physbeh.2007.05.039","article-title":"Ethanol alters the effect of kappa receptor ligands on dopamine release in the nucleus accumbens","volume":"92","author":"Lindholm","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.brainres.2018.09.023_b0435","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2018.09.023_b0440","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/mcne.1994.1015","article-title":"Kappa 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA","volume":"5","author":"Mansour","year":"1994","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0445","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(95)00928-J","article-title":"The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores","volume":"700","author":"Mansour","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.09.023_b0450","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/npp.2015.142","article-title":"Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress","volume":"41","author":"Mantsch","year":"2016","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0455","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cne.21464","article-title":"Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division","volume":"504","author":"Marchant","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2018.09.023_b0460","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1523\/JNEUROSCI.23-31-09981.2003","article-title":"Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons","volume":"23","author":"Margolis","year":"2003","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0465","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1152\/jn.00855.2004","article-title":"Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons","volume":"93","author":"Margolis","year":"2005","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.brainres.2018.09.023_b0470","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1073\/pnas.0511159103","article-title":"Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex","volume":"103","author":"Margolis","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.brainres.2018.09.023_b0475","doi-asserted-by":"crossref","first-page":"8908","DOI":"10.1523\/JNEUROSCI.1526-08.2008","article-title":"Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition","volume":"28","author":"Margolis","year":"2008","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0480","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fnins.2016.00480","article-title":"A trigger for opioid misuse: chronic pain and stress dysregulate the mesolimbic pathway and kappa opioid system","volume":"10","author":"Massaly","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0485","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.neuron.2014.04.030","article-title":"Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal","volume":"82","author":"Matsui","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0490","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0495","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.npp.1300860","article-title":"Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning","volume":"31","author":"McLaughlin","year":"2006","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0500","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1073\/pnas.90.21.9954","article-title":"Cloning and pharmacological characterization of a rat kappa opioid receptor","volume":"90","author":"Meng","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2018.09.023_b0505","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1471-4159.2006.03732.x","article-title":"Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor","volume":"97","author":"Merg","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2018.09.023_b0510","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/0006-291X(81)91243-2","article-title":"Beta-neo-endorphin, a new hypothalamic \u201cbig\u201d Leu-enkephalin of porcine origin: its purification and the complete amino acid sequence","volume":"99","author":"Minamino","year":"1981","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2018.09.023_b0515","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mcn.2009.10.001","article-title":"Cathepsin L participates in dynorphin production in brain cortex, illustrated by protease gene knockout and expression","volume":"43","author":"Minokadeh","year":"2010","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0520","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn.2016.165","article-title":"Ventral tegmental area: cellular heterogeneity, connectivity and behaviour","volume":"18","author":"Morales","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0525","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF00432213","article-title":"Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning","volume":"86","author":"Mucha","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0530","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/308278a0","article-title":"Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release","volume":"308","author":"Mulder","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2018.09.023_b0535","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0143-4179(89)90065-6","article-title":"Selectivity of various opioid peptides towards delta-, kappa; and mu-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain","volume":"14","author":"Mulder","year":"1989","journal-title":"Neuropeptides"},{"key":"10.1016\/j.brainres.2018.09.023_b0540","doi-asserted-by":"crossref","first-page":"E1648","DOI":"10.1073\/pnas.1315542111","article-title":"Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area","volume":"111","author":"Muschamp","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.brainres.2018.09.023_b0545","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.npp.1300858","article-title":"Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala","volume":"31","author":"Narita","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0550","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1523\/JNEUROSCI.22-24-10883.2002","article-title":"Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect","volume":"22","author":"Newton","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0555","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(82)90008-5","article-title":"Evidence that dynorphin-(1\u201313) acts as an agonist on opioid kappa-receptors","volume":"77","author":"Oka","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0560","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4088\/JCP.v69n0919c","article-title":"Toxic psychosis after intake of the hallucinogen salvinorin A","volume":"69","author":"Paulzen","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainres.2018.09.023_b0565","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.brainres.2018.09.023_b0570","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.neuron.2015.04.015","article-title":"Role of dopamine neurons in reward and aversion: a synaptic plasticity perspective","volume":"86","author":"Pignatelli","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0575","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1523\/JNEUROSCI.21-18-07397.2001","article-title":"Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens","volume":"21","author":"Pliakas","year":"2001","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0580","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2014.04.019","article-title":"Poststress block of kappa opioid receptors rescues long-term potentiation of inhibitory synapses and prevents reinstatement of cocaine seeking","volume":"76","author":"Polter","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.09.023_b0585","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23785","article-title":"Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress","volume":"6","author":"Polter","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.brainres.2018.09.023_b0590","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1476-5381.2012.02075.x","article-title":"Ligand-directed signalling within the opioid receptor family","volume":"167","author":"Pradhan","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0595","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1176\/appi.ajp.2009.08121759","article-title":"Persistent psychosis associated with salvia divinorum use","volume":"166","author":"Przekop","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2018.09.023_b0600","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nn.4281","article-title":"VTA glutamatergic inputs to nucleus accumbens drive aversion by acting on GABAergic interneurons","volume":"19","author":"Qi","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0605","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00213-008-1122-y","article-title":"Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system","volume":"200","author":"Redila","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0610","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/npp.2017.205","article-title":"Repeated administration of opra kappa (LY2456302), a novel, short-acting, selective KOP-r antagonist, in persons with and without cocaine dependence","volume":"43","author":"Reed","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0615","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00192549","article-title":"The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist","volume":"46","author":"Rimoy","year":"1994","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0620","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbr.2014.01.003","article-title":"Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females","volume":"262","author":"Robles","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2018.09.023_b0625","doi-asserted-by":"crossref","first-page":"13906","DOI":"10.1523\/JNEUROSCI.2029-14.2014","article-title":"Role of glutamatergic projections from ventral tegmental area to lateral habenula in aversive conditioning","volume":"34","author":"Root","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0630","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.brainres.2018.09.023_b0635","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0896-6273(03)00021-7","article-title":"Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons","volume":"37","author":"Saal","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0640","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/npp.2010.67","article-title":"Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin\/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms","volume":"35","author":"Schindler","year":"2010","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0645","doi-asserted-by":"crossref","first-page":"19384","DOI":"10.1523\/JNEUROSCI.1979-13.2013","article-title":"Long-term antagonism of kappa opioid receptors prevents escalation of and increased motivation for heroin intake","volume":"33","author":"Schlosburg","year":"2013","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0650","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.conb.2017.03.013","article-title":"The phasic dopamine signal maturing: from reward via behavioural activation to formal economic utility","volume":"43","author":"Schultz","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.brainres.2018.09.023_b0655","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1160575","article-title":"Dichotomous dopaminergic control of striatal synaptic plasticity","volume":"321","author":"Shen","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.brainres.2018.09.023_b0660","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3565(25)38109-7","article-title":"Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors","volume":"265","author":"Shippenberg","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2018.09.023_b0665","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","article-title":"Dynorphin and the pathophysiology of drug addiction","volume":"116","author":"Shippenberg","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2018.09.023_b0670","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","article-title":"Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects","volume":"90","author":"Shirayama","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2018.09.023_b0675","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1523\/JNEUROSCI.19-06-02347.1999","article-title":"Presynaptic inhibition of GABA(B)-mediated synaptic potentials in the ventral tegmental area during morphine withdrawal","volume":"19","author":"Shoji","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0680","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0026-895X(25)09167-9","article-title":"k-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release","volume":"50","author":"Simmons","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0685","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1360-0443.2007.01810.x","article-title":"Adolescent salvia substance abuse","volume":"102","author":"Singh","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.brainres.2018.09.023_b0690","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1126\/science.aah5234","article-title":"Midbrain dopamine neurons control judgment of time","volume":"354","author":"Soares","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.brainres.2018.09.023_b0695","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"PNAS"},{"key":"10.1016\/j.brainres.2018.09.023_b0700","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1126\/science.1160873","article-title":"Reward-predictive cues enhance excitatory synaptic strength onto midbrain dopamine neurons","volume":"321","author":"Stuber","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.brainres.2018.09.023_b0705","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.baga.2016.02.001","article-title":"Striatal dopamine neurotransmission: regulation of release and uptake","volume":"6","author":"Sulzer","year":"2016","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.brainres.2018.09.023_b0710","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.conb.2014.07.008","article-title":"Dopaminergic modulation of striatal networks in health and Parkinson's disease","volume":"29","author":"Surmeier","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.brainres.2018.09.023_b0715","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/syn.10005","article-title":"Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles","volume":"42","author":"Svingos","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2018.09.023_b0720","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00213-012-2752-7","article-title":"Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner","volume":"224","author":"Tejeda","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0725","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00018-011-0844-x","article-title":"The dynorphin\/kappa-opioid receptor system and its role in psychiatric disorders","volume":"69","author":"Tejeda","year":"2012","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"10.1016\/j.brainres.2018.09.023_b0730","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2013.76","article-title":"Prefrontal Cortical Kappa-Opioid Receptor Modulation of Local Neurotransmission and Conditioned Place Aversion","author":"Tejeda","year":"2013","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0735","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/npp.2015.138","article-title":"Prefrontal cortical kappa opioid receptors attenuate responses to amygdala inputs","volume":"40","author":"Tejeda","year":"2015","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0740","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuron.2016.12.005","article-title":"Pathway- and cell-specific kappa-opioid receptor modulation of excitation-inhibition balance differentially gates d1 and d2 accumbens neuron activity","volume":"93","author":"Tejeda","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0745","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1523\/JNEUROSCI.20-24-09333.2000","article-title":"Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine","volume":"20","author":"Thompson","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0750","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-003-1680-y","article-title":"Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats","volume":"172","author":"Todtenkopf","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0755","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2012.09.023","article-title":"Dopaminergic modulation of synaptic transmission in cortex and striatum","volume":"76","author":"Tritsch","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0760","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neubiorev.2010.04.006","article-title":"Effects of stress and aversion on dopamine neurons: implications for addiction","volume":"35","author":"Ungless","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainres.2018.09.023_b0765","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjp.0700971","article-title":"The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man","volume":"120","author":"Ur","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.09.023_b0770","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00213-017-4647-0","article-title":"Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats","volume":"234","author":"Valenza","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0775","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-013-3195-5","article-title":"Role of kappa-opioid receptors in stress and anxiety-related behavior","volume":"229","author":"Van't Veer","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0780","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0304-3940(82)90249-X","article-title":"Dynorphin-immunoreactive neurons in the central nervous system of the rat","volume":"33","author":"Vincent","year":"1982","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.09.023_b0785","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.npp.1301438","article-title":"Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence","volume":"33","author":"Walker","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0790","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s002130100788","article-title":"Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans","volume":"157","author":"Walsh","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0795","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1113\/jphysiol.2007.150078","article-title":"Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih","volume":"586","author":"Wanat","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.brainres.2018.09.023_b0800","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1073\/pnas.90.21.10230","article-title":"mu opiate receptor: cDNA cloning and expression","volume":"90","author":"Wang","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2018.09.023_b0805","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.neuron.2012.03.017","article-title":"Whole-brain mapping of direct inputs to midbrain dopamine neurons","volume":"74","author":"Watabe-Uchida","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0810","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-010-1825-8","article-title":"The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse","volume":"210","author":"Wee","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0815","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuron.2015.12.029","article-title":"Dopamine does double duty in motivating cognitive effort","volume":"89","author":"Westbrook","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.09.023_b0820","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1523\/JNEUROSCI.1978-13.2015","article-title":"kappa Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake","volume":"35","author":"Whitfield","year":"2015","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0825","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2018.09.023_b0830","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/npp.2008.142","article-title":"Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone","volume":"34","author":"Wittmann","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.09.023_b0835","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1113\/jphysiol.2010.188367","article-title":"Substance P inhibits GABAB receptor signalling in the ventral tegmental area","volume":"588","author":"Xia","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.brainres.2018.09.023_b0840","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1126\/science.1255514","article-title":"A critical time window for dopamine actions on the structural plasticity of dendritic spines","volume":"345","author":"Yagishita","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.brainres.2018.09.023_b0845","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0306-4522(94)90540-1","article-title":"The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis\u2013II. Effects of dopamine D1 and D2 receptor agonists","volume":"63","author":"You","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.09.023_b0850","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.ajp.2015.15040535","article-title":"Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: a randomized controlled trial","volume":"173","author":"Yovell","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2018.09.023_b0855","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-8993(83)91176-9","article-title":"Distribution of immunoreactive dynorphin in the central nervous system of the rat","volume":"280","author":"Zamir","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.09.023_b0860","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0006-8993(84)90460-8","article-title":"Distribution of immunoreactive dynorphin A1\u20138 in discrete nuclei of the rat brain: comparison with dynorphin A","volume":"307","author":"Zamir","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.09.023_b0865","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-8993(84)91346-5","article-title":"Distribution of immunoreactive dynorphin B in discrete areas of the rat brain and spinal cord","volume":"300","author":"Zamir","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.09.023_b0870","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0143-4179(85)90049-6","article-title":"Dynorphinergic pathways of Leu-enkephalin production in the rat brain","volume":"5","author":"Zamir","year":"1985","journal-title":"Neuropeptides"},{"key":"10.1016\/j.brainres.2018.09.023_b0875","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1073\/pnas.81.21.6886","article-title":"Differential processing of prodynorphin and proenkephalin in specific regions of the rat brain","volume":"81","author":"Zamir","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2018.09.023_b0880","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)37567-6","article-title":"Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family","volume":"286","author":"Zhang","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318304888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318304888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:00:14Z","timestamp":1757786414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899318304888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":176,"alternative-id":["S0006899318304888"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2018.09.023","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynorphin\/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2018.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}